KLEMP WALTER V (CEO and President) exercised options at MOLECULIN BIOTECH, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 7/13/2023ACC: 0001437749-23-019907
DirectorOfficer· CEO and President
Since Jul 2019
-3.22K
Net shares
Net seller
$1.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
13.20K acquired · 16.42K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13.20K
Price / share
—
Trade value
—
% of position
2.7%
7/11/2023
482.49K→495.69K
Common Stock
Direct
Shares
−3.22K
Price / share
$0.59
Trade value
$1.90K
% of position
0.6%
7/11/2023
495.69K→492.48K
Total
Net shares
+9.99K
Net value
-$1.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/11/2023 | M · Option Exercise | +13.20K | — | — | 2.7% | 482.49K | 495.69K |
| Common Stock Direct | 7/11/2023 | F · Tax Withholding | −3.22K | $0.59 | $1.90K | 0.6% | 495.69K | 492.48K |
| Total | +9.99K | -$1.90K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
13.20K shares
Shares
−13.20K
Strike price
Held after
1.93M
Exercisable
—
7/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock13.20K shares | 7/11/2023 | M · Option Exercise | −13.20K | — | 1.93M |